HIGH RESOLUTION ELECTRON MICROSCOPY FACILITY (HREMF) The mission of the High Resolution Electron Microscopy Facility (HREMF) is to provide high-quality, affordable electron microscopy services to research investigators at MD Anderson Cancer Center. The facility is in the Smith Research Building and houses a JEOL JEM 1010 transmission electron microscope, a JEOL JSM 5900 scanning electron microscope, a TechnoTrade coating system, a Leica ultramicrotome, and a Leica ultrastainer. Dr. Robert Langley has directed the HREMF for the past 10 years and has 20 years of experience in microscopic imaging of tissues and cells. Kenneth Dunner, Jr, is the manager of the HREMF and is responsible for the daily operations of the facility, including processing and imaging of samples. The HREMF houses the only scanning electron microscope on campus and the only transmission electron microscope that is dedicated to research applications. Since its inception in 1997, the HREMF has received approximately $500,000 in capital equipment funds from MD Anderson. In grant Yr42, 89% of the total usage of the HREMF was by peer-reviewed funded faculty, and we are requesting 55% of the HREMF budget from the CCSG ($106,740). During the past 6 years, the HREMF has provided 6759 hours of service to 164 investigators, 132 of whom were cancer center members representing all 16 CCSG programs. Usage was well distributed among the CCSG programs, and no program accounted for more than 15% of the HREMF's resources. The facility also ranked near the top of a user satisfaction survey and made regular contributions to high-impact publications. The HREMF contributed to 124 publications in peer-reviewed journals, with 88 publications (71%) in journals with IF >5 and 31 publications (25%) in journals with IF >10, including Nature (5 articles), Nat Cell Biol (3 articles), Nat Commun (2 articles), Cancer Cell, Nat Immunol, and Nat Nanotechnol. The HREMF's Specific Aims are:
Aim 1 : To provide MD Anderson Cancer Center investigators with access to microscopy instruments necessary to perform research at the ultrastructural level.
Aim 2 : To provide complete electron microscopy specimen preparation services.
Aim 3 : To provide technical assistance and consultation for electron microscopy applications.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA016672-44
Application #
9997802
Study Section
Subcommittee I - Transistion to Independence (NCI)
Project Start
Project End
Budget Start
2020-07-01
Budget End
2021-06-30
Support Year
44
Fiscal Year
2020
Total Cost
Indirect Cost
Name
University of Texas MD Anderson Cancer Center
Department
Type
DUNS #
800772139
City
Houston
State
TX
Country
United States
Zip Code
77030
Chang, Geraldine H; Kurzrock, Razelle; Tran, Lisa et al. (2018) TP53 mutations and number of alterations correlate with maximum standardized uptake value (SUVmax) determined by positron emission tomography/computed tomography (PET/CT) [18F] fluorodeoxyglucose (18F-FDG PET). Oncotarget 9:14306-14310
Abaza, Yasmin; Cortes, Jorge; Ravandi, Farhad et al. (2018) Prognostic significance of hyperdiploidy in adult acute myeloid leukemia. Am J Hematol 93:E357-E360
Ellrott, Kyle; Bailey, Matthew H; Saksena, Gordon et al. (2018) Scalable Open Science Approach for Mutation Calling of Tumor Exomes Using Multiple Genomic Pipelines. Cell Syst 6:271-281.e7
White, Matthew C; Schroeder, Rebecca D; Zhu, Keyi et al. (2018) HRI-mediated translational repression reduces proteotoxicity and sensitivity to bortezomib in human pancreatic cancer cells. Oncogene 37:4413-4427
Abaza, Yasmin; Hidalgo-Lopez, Juliana E; Verstovsek, Srdan et al. (2018) Phase I study of ruxolitinib in previously treated patients with low or intermediate-1 risk myelodysplastic syndrome with evidence of NF-kB activation. Leuk Res 73:78-85
McGrail, Daniel J; Federico, Lorenzo; Li, Yongsheng et al. (2018) Multi-omics analysis reveals neoantigen-independent immune cell infiltration in copy-number driven cancers. Nat Commun 9:1317
Li, Carrie J; Jiang, Changying; Liu, Yang et al. (2018) Pleiotropic Action of Novel Bruton's Tyrosine Kinase Inhibitor BGB-3111 in Mantle Cell Lymphoma. Mol Cancer Ther :
Morita, Kiyomi; Kantarjian, Hagop M; Wang, Feng et al. (2018) Clearance of Somatic Mutations at Remission and the Risk of Relapse in Acute Myeloid Leukemia. J Clin Oncol 36:1788-1797
Raber, Benjamin; Bea, Vivian J; Bedrosian, Isabelle (2018) How Does MR Imaging Help Care for My Breast Cancer Patient? Perspective of a Surgical Oncologist. Magn Reson Imaging Clin N Am 26:281-288
Li, Roger; Metcalfe, Michael J; Ferguson 3rd, James E et al. (2018) Effects of thiazolidinedione in patients with active bladder cancer. BJU Int 121:244-251

Showing the most recent 10 out of 12418 publications